Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis
Research output: Contribution to journal › Journal article › Research › peer-review
Worldwide, more than 400 million individuals have allergic rhinitis, which has a significant impact on the individual's general health. Most patients self-medicate with over-the-counter drugs, but severe cases need treatment with topical corticosteroids and/or immunotherapy (SCIT). Although the ARIA guidelines discourage the use of systemic corticosteroids, this treatment is often used by general practitioners.
Original language | English |
---|---|
Journal | Allergy: European Journal of Allergy and Clinical Immunology |
Volume | 67 |
Issue number | 11 |
Pages (from-to) | 1423-9 |
Number of pages | 7 |
ISSN | 0105-4538 |
DOIs | |
Publication status | Published - 2012 |
ID: 48420676